Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozden Altundag

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Current Oncology (Toronto, Ont.)|January 27, 2026
Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival PerspectiveAydan Farzaliyeva, Huseyin Akilli, Ozden Altundag, et al.
Breast Care (Basel, Switzerland)|June 25, 2026
Gender Disparities in Response to Neoadjuvant Therapy for Early-Stage Breast Cancer: A Propensity Score-Matched Analysis of the SEER DatabaseRashad Ismayilov, Arzu Oguz, Zafer Akcali, et al.
Immunotherapy|June 15, 2026
Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy erasRashad Ismayilov, Ulkar Ismayilova, Arzu Oguz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanesNadire Kucukoztas, Arzu Oguz, Samed Rahatli, et al.
Medical Hypotheses|June 15, 2004
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cellsKadri Altundag, Ozden Altundag, Emin Tamer Elkiran, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|August 19, 2018
Posttransplant Malignancies in Adult Renal and Hepatic Transplant PatientsSamed Rahatli, Ozden Altundag, Ebru Ayvazoglu Soy, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Assessment of Large Language Models in Colorectal Cancer Multidisciplinary Tumor Board Decision-Making: A Retrospective Single-Center Comparison of Guideline-Integrated General-Purpose vs. Domain-Specialized ModelsAydan Farzaliyeva, Mehmet Nezir Ramazanoglu, Arzu Oguz, et al.
In Vivo (Athens, Greece)|June 30, 2026
Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver TransplantationAydan Farzaliyeva, Mehmet Nezir Ramazanoglu, Arzu Oguz, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 9, 2022
Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre studyHuseyin Akilli, Samed Rahatli, Khayala Aliyeva, et al.
Molecular Imaging and Biology|December 5, 2025
Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT ReportsRashad Ismayilov, Ayse Aktas, Esra Arzu Gencoglu, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|January 27, 2026
Shifting Survival Horizons in Advanced Ovarian Cancer: A Conditional Survival PerspectiveAydan Farzaliyeva, Huseyin Akilli, Ozden Altundag, et al.
Breast Care (Basel, Switzerland)|June 25, 2026
Gender Disparities in Response to Neoadjuvant Therapy for Early-Stage Breast Cancer: A Propensity Score-Matched Analysis of the SEER DatabaseRashad Ismayilov, Arzu Oguz, Zafer Akcali, et al.
Immunotherapy|June 15, 2026
Time-dependent prognostic impact of distant metastatic sites in small cell lung cancer: a comparative analysis of pre- and post-immunotherapy erasRashad Ismayilov, Ulkar Ismayilova, Arzu Oguz, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanesNadire Kucukoztas, Arzu Oguz, Samed Rahatli, et al.
Medical Hypotheses|June 15, 2004
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cellsKadri Altundag, Ozden Altundag, Emin Tamer Elkiran, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|August 19, 2018
Posttransplant Malignancies in Adult Renal and Hepatic Transplant PatientsSamed Rahatli, Ozden Altundag, Ebru Ayvazoglu Soy, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Assessment of Large Language Models in Colorectal Cancer Multidisciplinary Tumor Board Decision-Making: A Retrospective Single-Center Comparison of Guideline-Integrated General-Purpose vs. Domain-Specialized ModelsAydan Farzaliyeva, Mehmet Nezir Ramazanoglu, Arzu Oguz, et al.
In Vivo (Athens, Greece)|June 30, 2026
Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver TransplantationAydan Farzaliyeva, Mehmet Nezir Ramazanoglu, Arzu Oguz, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|March 9, 2022
Survival in recurrent ovarian cancer patients before and after the bevacizumab era: an observational single-centre studyHuseyin Akilli, Samed Rahatli, Khayala Aliyeva, et al.
Molecular Imaging and Biology|December 5, 2025
Staging Prostate Cancer with AI: A Comparative Study of Large Language Models and Expert Interpretation on PSMA PET-CT ReportsRashad Ismayilov, Ayse Aktas, Esra Arzu Gencoglu, et al.
Pageof 5